Facebook
Twitter
Telegram
Report an ErrorFlexion Therapeutics, Inc. Financial Statements 2011-2024 | FLXN
Annual Financial Statements Flexion Therapeutics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
521 M | 665 M | 537 M | 768 M | 473 M | 333 M | 286 M | - | - | - |
Shares |
42.8 M | 38.1 M | 37.8 M | 33 M | 25.3 M | 21.5 M | 13.9 M | - | - | - |
Net Income |
-114 M | -150 M | -170 M | -137 M | -71.9 M | -46.3 M | -27.3 M | -18.2 M | -15 M | -11.4 M |
Revenue |
85.6 M | 73 M | 22.5 M | 355 K | - | - | - | - | - | - |
EBITDA |
-89.7 M | -134 M | -157 M | -128 M | -68.6 M | -45.8 M | -26.9 M | -17.7 M | -14.9 M | -11.3 M |
Operating Expenses |
159 M | 199 M | 174 M | 130 M | 69.8 M | 46.1 M | 27 M | - | - | - |
General and Administrative Expenses |
105 M | 130 M | 121 M | 78.8 M | 28.5 M | 13.4 M | 9.06 M | 6.7 M | 3.95 M | 3.05 M |
All numbers in USD currency